Abstract
The main aim of this work is to introduce new features for the automated evaluation of fluorescence signals of methylated and global DNA, to quickly and objectively measure changes resulting from a demethylating anti-cancer drug application in cell nuclei. Drug response can be monitored in a high-content fashion by means of three dimensional (3-D) image cytometry. This technique enables extraction of basic DNA signal intensities that can be converted to more sophisticated features such as a codistribution and its derivatives. In this work, a slope of nuclear DNA codistribution patterns extracted from individual cells, and whole cell populations and divergences between DNA codistributions of untreated as well as drug treated cells were analysed. A progressive decrease of the slope and an increase of the divergence observed for low drug concentrations suggest that these features can be essential for high-content screening of agents with demethylating potency.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Perlman, Z.E., Slack, M.D., Feng, Y., Mitchison, T.J., Wu, L.F., Altschuler, S.J.: Multidimensional drug profiling by automated microscopy. Science 306, 1194–1198 (2004)
Tkaczuk, K.H., Tait, N.S., Ioffe, O., Tan, M., Goloubeva, O.G., Lesko, S.A., Deamond, S.F., Zhou, D., Lum, Z.P., Sutula, M.J., Van Echo, D., Tsó, P.O.: Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients. Discov. Med. 62, 33–40 (2011)
Hoffman, A.F., Garippa, R.: A pharmaceutical company user’s perspective on the potential of high content screening in drug discovery. Methods. Mol. Biol. 356, 19–31 (2007)
Herceg, Z., Hainauta, P.: Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol. Oncol. 1, 26–41 (2007)
Villar-Garea, A., Esteller, M.: DNA demethylating agents and chromatin-remodelling drugs: which, how and why? Curr. Drug. Metab. 1, 11–31 (2003)
Lübbert, M.: DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr. Top. Microbiol. Immunol. 249, 135–164 (2000)
Gama-Sosa, M.A., Slagel, V.A., Trewyn, R.W., Oxenhandler, R., Kuo, K.C., Gehrke, C.W., Ehrlich, M.: The 5-methylcytosine content of DNA from human tumors. Nuclecic Acids Res. 11, 6883–6894 (1983)
Feinberg, A.P., Vogelstein, B.: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983)
Ting, A., McGarvey, K., Baylin, S.: The cancer epigenome-components and functional correlates. Genes. Dev. 20, 3215–3231 (2006)
Tajbakhsh, J., Wawrowsky, K., Gertych, A., Bar-Nur, O., Vishnevsky, E., Lindsley, E., Farkas, D.L.: Characterization of tumor cells and stem cells by differential nuclear methylation imaging. In: Farkas, D.L., Nicolau, D., Leif, R.C. (eds.) Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues, vol. 6859, p. 68590F. SPIE, San Jose (2008)
Gertych, A., Wawrowsky, K., Lindsley, E., Vishnewsky, E., Farkas, D., Tajbakhsh, J.: Automated quantification of DNA demethylation effects in cells via 3D mapping of nuclear signatures and population homogeneity assessment. Cytom. Part A 75, 569–583 (2009)
Gertych, A., Farkas, D., Tajbakhsh, J.: Measuring topology of low-intensity DNA methylation sites for high-throughput assessment of epigenetic drug-induced effects in cancer cells. Exp. Cell. Res. 316, 3150–3160 (2010)
Christman, J.K.: 5-Azacytidine and 5-aza-2-́deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483–5495 (2002)
Zinchuk, V., Zinchuk, O., Okada, T.: Quantitative Colocalization Analysis of Multicolor Confocal Immunofluorescence. Microscopy Images: Pushing Pixels to Explore Biological Phenomena. Acta Histochem. Cytochem. 40, 101–111 (2007)
Carpenter, A.E.: Image-based chemical screening. Nature Chemical Biology 3, 461–465 (2007)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gertych, A. (2012). Features of DNA Signals Codistribution in High-Content Screening of Drug-Induced Demethylation in Cancer Cells. In: Piętka, E., Kawa, J. (eds) Information Technologies in Biomedicine. Lecture Notes in Computer Science(), vol 7339. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31196-3_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-31196-3_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31195-6
Online ISBN: 978-3-642-31196-3
eBook Packages: Computer ScienceComputer Science (R0)